SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Disciplined Investing, especially the NAIC way

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: EL KABONG!!! who wrote (462)4/12/2004 6:07:02 PM
From: The Philosopher  Read Replies (1) of 469
 
My investment club used to own JNJ before we closed shop permanently. We had sold them at around 55 or so, back in 2001. We used the proceeds to buy Pfizer (PFE). Neither stock has been a real good performer since then. JNJ is currently selling for less than what we sold for over 2 years ago now. And PFE is up only 10%, give or take, in the same time frame. The price of JNJ stock has been pretty much range-bound since late 2000.

Which means, given that it has been growing sales all that time, that when it does break out it will do so nicely. I hope!

Priority Healthcare... Interesting company... Fantastic numbers as projected by Value Line... I like them at or under $19. If you decide to buy, let the thread know so we can front-run you on the stock... <ggg>

Better you short them -- it seems that my decision to enter an order is a guarantee that the stock price will drop!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext